The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.
Gauci ML, Giustiniani J, Lepelletier C, Garbar C, Thonnart N, Dumaz N, Foussat A, Lebbé C, Bensussan A, Marie-Cardine A.
Gauci ML, et al. Among authors: garbar c.
Cancer Immunol Immunother. 2022 Nov;71(11):2731-2742. doi: 10.1007/s00262-022-03199-0. Epub 2022 Apr 15.
Cancer Immunol Immunother. 2022.
PMID: 35428910
Free PMC article.